Publication

Acute Stroke Management in Patients Taking Dabigatran

Brouns, R., Van Hooff, R-J., De Smedt, A., Moens, M., De Raedt, S., Uyttenboogaart, M., Luijckx, G-J., Jochmans, K. & De Keyser, J., Aug-2012, In : CNS Neuroscience & Therapeutics. 18, 8, p. 616-622 7 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Dabigatran etexilate is emerging as an alternative for vitamin K antagonists, but evidence-based guidelines for management of intracerebral hemorrhage and acute ischemic stroke in patients taking this drug are nonexistent. This review summarizes current knowledge on key pharmacological features and the assessment of dabigatran activity. Pragmatic approaches are provided for individualized decision taking with regard to hemostatic therapy and reperfusion strategies in acute stroke patients.

Original languageEnglish
Pages (from-to)616-622
Number of pages7
JournalCNS Neuroscience & Therapeutics
Volume18
Issue number8
Publication statusPublished - Aug-2012

    Keywords

  • Acute stroke, Dabigatran etexilate, Hemostasis, Reperfusion, ACUTE ISCHEMIC-STROKE, ORAL DIRECT THROMBIN, TISSUE-PLASMINOGEN ACTIVATOR, QUALITY-OF-CARE, INTRACEREBRAL HEMORRHAGE, VENOUS THROMBOEMBOLISM, THROMBOLYTIC THERAPY, ATRIAL-FIBRILLATION, INHIBITOR DABIGATRAN, ETEXILATE

Download statistics

No data available

ID: 5627675